Fastnet Chief Explains Switch to Pharma - Raglan Capital

Home
About Us
- Why Raglan
- Careers
Selected Transactions
Fundraising and Financial Support
Raglan IPO Projects
- Raglan Pharmaceutical & Life Science Projects
- Raglan Natural Resources
News
Contact us

Search

Fastnet Chief Explains Switch to Pharma

Home
Fastnet Equity
Fastnet Chief Explains Switch to Pharma

Recent News

Open Orphan in German pharma deal
Open Orphan signs ‘significant’ revenue generating contract
Open Orphan in line to take stake in ‘$1bn’ flu drug
Amryt says integration of acquired company Aegerion ‘progressing well’
Open Orphan recruits hVIVO for its rare disease mission
Open Orphan to buy hVIVO in £30m merger deal

05 April 2016

Fastnet chief explains switch to pharma 05 April 2016 online article

Add comment Cancel reply

Comment

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Prev
Next

Raglan Capital
18 Fitzwilliam Place, Dublin 2.
T: +353 (01) 6440007
E: info@raglancapital.ie

Email us for our newsletters

Contact us
Careers

Share our site